Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jupiter Neurosciences (JUNS) Current Deferred Revenue (2025)

Jupiter Neurosciences (JUNS) has disclosed Current Deferred Revenue for 1 consecutive years, with $735.0 as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue changed N/A to $735.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $735.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $735.0 for FY2025, N/A changed from the prior year.
  • Current Deferred Revenue for Q4 2025 was $735.0 at Jupiter Neurosciences, down from $6695.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $6695.0 in Q3 2025, with the low at $735.0 in Q4 2025.